CRP and hemophagocytic syndrome: Indeed, in some trials, HLH parameters, such as fever, leukopenia, increased ferritin, and LDH levels, were used, while others based the therapy solely on increased inflammatory markers, such as high-sensitivity C-reactive protein (hs-CRP) [21,36,37,38].